Advanced Glycation End Products Stimulate Angiotensinogen Production in Renal Proximal Tubular Cells

American Journal of the Medical Sciences

Volumn 357, Issue 1, 2019, Pages 57-66

  Garagliano, Joseph M ^a   Katsurada, Akemi ^a   Miyata, Kayoko ^a   Derbenev, Andrei V ^a   Zsombok, Andrea ^a   Navar, L Gabriel ^a   Satou, Ryousuke ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Advanced glycation end products; Angiotensinogen; Diabetes mellitus; Kidney; Renal proximal tubules

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; ANGIOTENSINOGEN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; STREPTOZOCIN; STRESS ACTIVATED PROTEIN KINASE; AGT PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME SYNTHESIS; INTRACELLULAR SIGNALING; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN RNA BINDING; PROTEIN SECRETION; UPREGULATION; ANIMAL; C57BL MOUSE; CELL CULTURE; EXPERIMENTAL DIABETES MELLITUS; METABOLISM; PHYSIOLOGY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SIGNAL TRANSDUCTION;

ANGIOTENSINOGEN; ANIMALS; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; GLYCATION END PRODUCTS, ADVANCED; KIDNEY TUBULES, PROXIMAL; MALE; MICE; MICE, INBRED C57BL; RENIN-ANGIOTENSIN SYSTEM; SIGNAL TRANSDUCTION;

EID: 85056756944     PISSN: 00029629     EISSN: 15382990     Source Type: Journal    
DOI: 10.1016/j.amjms.2018.10.008     Document Type: Article

References (55)

1. Ozieh, M.N., Dismuke, C.E., Lynch, C.P., et al. Medical care expenditures associated with chronic kidney disease in adults with diabetes: United States 2011. Diabetes Res Clin Pract 109 (2015), 185–190.
2. Schena, F.P., Gesualdo, L., Pathogenetic mechanisms of diabetic nephropathy. J Am Soc Nephrol 16:Suppl 1 (2005), S30–S33.
3. Elmarakby, A.A., Abdelsayed, R., Yao Liu, J., et al. Inflammatory cytokines as predictive markers for early detection and progression of diabetic nephropathy. EPMA J 1 (2010), 117–129.
4. Varga, Z.V., Giricz, Z., Liaudet, L., et al. Interplay of oxidative, nitrosative/nitrative stress, inflammation, cell death and autophagy in diabetic cardiomyopathy. Biochim Biophys Acta 1852 (2015), 232–242.
5. Goutos, I., Nicholas, R.S., Pandya, A.A., et al. Diabetes mellitus and burns. Part I-basic science and implications for management. Int J Burns Trauma 5 (2015), 1–12.
6. Singh, R., Barden, A., Mori, T., et al. Advanced glycation end-products: a review. Diabetologia 44 (2001), 129–146.
7. Vincent, A.M., Perrone, L., Sullivan, K.A., et al. Receptor for advanced glycation end products activation injures primary sensory neurons via oxidative stress. Endocrinology 148 (2007), 548–558.
8. Grimm, S., Ott, C., Horlacher, M., et al. Advanced-glycation-end-product-induced formation of immunoproteasomes: involvement of RAGE and Jak2/STAT1. Biochem J 448 (2012), 127–139.
9. Yu, L., Zhao, Y., Xu, S., et al. Advanced Glycation End Product (AGE)-AGE Receptor (RAGE) System Upregulated Connexin43 Expression in Rat Cardiomyocytes via PKC and Erk MAPK Pathways. Int J Mol Sci 14 (2013), 2242–2257.
10. Hu, P., Lai, D., Lu, P., et al. ERK and Akt signaling pathways are involved in advanced glycation end product-induced autophagy in rat vascular smooth muscle cells. Int J Mol Med 29 (2012), 613–618.
11. Lu, C., He, J.C., Cai, W., et al. Advanced glycation endproduct (AGE) receptor 1 is a negative regulator of the inflammatory response to AGE in mesangial cells. Proc Natl Acad Sci USA 101 (2004), 11767–11772.
12. Chen, H., Liu, W., Wu, X., et al. Advanced glycation end products induced IL-6 and VEGF-A production and apoptosis in osteocyte-like MLO-Y4 cells by activating RAGE and ERK1/2, P38 and STAT3 signalling pathways. Int Immunopharmacol 52 (2017), 143–149.
13. Cheng, A., Dong, Y., Zhu, F., et al. AGE-LDL activates Toll like receptor 4 pathway and promotes inflammatory cytokines production in renal tubular epithelial cells. Int J Biol Sci 9 (2013), 94–107.
14. Mercado-Pimentel, M.E., Onyeagucha, B.C., Li, Q., et al. The S100P/RAGE signaling pathway regulates expression of microRNA-21 in colon cancer cells. FEBS lett 589 (2015), 2388–2393.
15. Yamamoto, Y., Kato, I., Doi, T., et al. Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice. J Clin Invest 108 (2001), 261–268.
16. Navar, L.G., Prieto, M.C., Satou, R., et al. Intrarenal angiotensin II and its contribution to the genesis of chronic hypertension. Curr Opin Pharmacol 11 (2011), 180–186.
17. Miyata, K., Ohashi, N., Suzaki, Y., et al. Sequential activation of the reactive oxygen species/angiotensinogen/renin-angiotensin system axis in renal injury of type 2 diabetic rats. Clin Exp Pharmacol Physiol 35 (2008), 922–927.
18. Park, S., Bivona, B.J., Kobori, H., et al. Major role for ACE-independent intrarenal ANG II formation in type II diabetes. Am J Physiol Renal Physiol 298 (2010), F37–F48.
19. Kamiyama, M., Zsombok, A., Kobori, H., Urinary angiotensinogen as a novel early biomarker of intrarenal renin-angiotensin system activation in experimental type 1 diabetes. J Pharmacol Sci 119 (2012), 314–323.
20. Hsieh, T.J., Fustier, P., Wei, C.C., et al. Reactive oxygen species blockade and action of insulin on expression of angiotensinogen gene in proximal tubular cells. J Endocrinol 183 (2004), 535–550.
21. Satou, R., Miyata, K., Gonzalez-Villalobos, R.A., et al. Interferon-gamma biphasically regulates angiotensinogen expression via a JAK-STAT pathway and suppressor of cytokine signaling 1 (SOCS1) in renal proximal tubular cells. FASEB J 26 (2012), 1821–1830.
22. Satou, R., Gonzalez-Villalobos, R.A., Miyata, K., et al. Costimulation with angiotensin II and interleukin 6 augments angiotensinogen expression in cultured human renal proximal tubular cells. Am J Physiol Renal Physiol 295 (2008), F283–F289.
23. Acres, O.W., Satou, R., Navar, L.G., et al. Contribution of a nuclear factor-kappaB binding site to human angiotensinogen promoter activity in renal proximal tubular cells. Hypertension 57 (2011), 608–613.
24. Uhal, B.D., Zhang, H., Abdul-Hafez, A., et al. Amiodarone induces angiotensinogen gene expression in lung alveolar epithelial cells through activation protein-1. Basic Clin Pharmacol Toxicol 100 (2007), 59–66.
25. Ingelfinger, J.R., Jung, F., Diamant, D., et al. Rat proximal tubule cell line transformed with origin-defective SV40 DNA: autocrine ANG II feedback. Am J Physiol 276 (1999), F218–F227.
26. Koyama, H., Yamamoto, H., Nishizawa, Y., RAGE and soluble RAGE: potential therapeutic targets for cardiovascular diseases. Mol Med 13 (2007), 625–635.
27. Kobori, H., Katsurada, A., Miyata, K., et al. Determination of plasma and urinary angiotensinogen levels in rodents by newly developed ELISA. Am J Physiol Renal Physiol 294 (2008), F1257–F1263.
28. O'Leary, R., Penrose, H., Miyata, K., et al. Macrophage-derived IL-6 contributes to ANG II-mediated angiotensinogen stimulation in renal proximal tubular cells. Am J Physiol Renal Physiol 310 (2016), F1000–F1007.
29. Fukami, K., Yamagishi, S., Coughlan, M.T., et al. Ramipril inhibits AGE-RAGE-induced matrix metalloproteinase-2 activation in experimental diabetic nephropathy. Diabetol Metab Syndr, 6, 2014, 86.
30. Liu, J., Huang, K., Cai, G.Y., et al. Receptor for advanced glycation end-products promotes premature senescence of proximal tubular epithelial cells via activation of endoplasmic reticulum stress-dependent p21 signaling. Cell signal 26 (2014), 110–121.
31. Hermani, A., De Servi, B., Medunjanin, S., et al. S100A8 and S100A9 activate MAP kinase and NF-kappaB signaling pathways and trigger translocation of RAGE in human prostate cancer cells. Exp Cell Res 312 (2006), 184–197.
32. Wei, W., Lampe, L., Park, S., et al. Disulfide bonds within the C2 domain of RAGE play key roles in its dimerization and biogenesis. PloS One, 7, 2012, e50736.
33. Tuttle, K.R., Bakris, G.L., Bilous, R.W., et al. Diabetic kidney disease: a report from an ADA Consensus Conference. Am J Kidney Dis 64 (2014), 510–533.
34. Yacoub, R., Campbell, K.N., Inhibition of RAS in diabetic nephropathy. Int J Nephrol Renovasc Dis 8 (2015), 29–40.
35. Abdo, S., Lo, C.S., Chenier, I., et al. Heterogeneous nuclear ribonucleoproteins F and K mediate insulin inhibition of renal angiotensinogen gene expression and prevention of hypertension and kidney injury in diabetic mice. Diabetologia 56 (2013), 1649–1660.
36. Wang, J., Shibayama, Y., Kobori, H., et al. High glucose augments angiotensinogen in human renal proximal tubular cells through hepatocyte nuclear factor-5. PLoS One, 12, 2017, e0185600.
37. Cheng, C.L., Tang, Y., Zheng, Z., et al. Advanced glycation end-products activate the renin-angiotensin system through the RAGE/PI3-K signaling pathway in podocytes. Clin Invest Med, 35, 2012, E282.
38. Ohashi, N., Urushihara, M., Satou, R., et al. Glomerular angiotensinogen is induced in mesangial cells in diabetic rats via reactive oxygen species–ERK/JNK pathways. Hypertens Res 33 (2010), 1174–1181.
39. Ingelfinger, J.R., Zuo, W.M., Fon, E.A., et al. In situ hybridization evidence for angiotensinogen messenger RNA in the rat proximal tubule. An hypothesis for the intrarenal renin angiotensin system. J Clin Invest 85 (1990), 417–423.
40. Kobori, H., Harrison-Bernard, L.M., Navar, L.G., Expression of angiotensinogen mRNA and protein in angiotensin II-dependent hypertension. J Am Soc Nephrol 12 (2001), 431–439.
41. Terada, Y., Tomita, K., Nonoguchi, H., et al. PCR localization of angiotensin II receptor and angiotensinogen mRNAs in rat kidney. Kidney Int 43 (1993), 1251–1259.
42. Pohl, M., Kaminski, H., Castrop, H., et al. Intrarenal renin angiotensin system revisited: role of megalin-dependent endocytosis along the proximal nephron. J Biol Chem 285 (2010), 41935–41946.
43. Sachetelli, S., Liu, Q., Zhang, S.L., et al. RAS blockade decreases blood pressure and proteinuria in transgenic mice overexpressing rat angiotensinogen gene in the kidney. Kidney Int 69 (2006), 1016–1023.
44. Ying, J., Stuart, D., Hillas, E., et al. Overexpression of mouse angiotensinogen in renal proximal tubule causes salt-sensitive hypertension in mice. Am J Hypertens 25 (2012), 684–689.
45. Park, L., Raman, K.G., Lee, K.J., et al. Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts. Nat Med 4 (1998), 1025–1031.
46. Kislinger, T., Tanji, N., Wendt, T., et al. Receptor for advanced glycation end products mediates inflammation and enhanced expression of tissue factor in vasculature of diabetic apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol 21 (2001), 905–910.
47. Wendt, T.M., Tanji, N., Guo, J., et al. RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy. Am J Pathol 162 (2003), 1123–1137.
48. Chen, Y., Yan, S.S., Colgan, J., et al. Blockade of late stages of autoimmune diabetes by inhibition of the receptor for advanced glycation end products. J Immunol 173 (2004), 1399–1405.
49. Bucciarelli, L.G., Wendt, T., Qu, W., et al. RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice. Circulation 106 (2002), 2827–2835.
50. Goh, S.Y., Cooper, M.E., Clinical review: The role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab 93 (2008), 1143–1152.
51. Sourris, K.C., Morley, A.L., Koitka, A., et al. Receptor for AGEs (RAGE) blockade may exert its renoprotective effects in patients with diabetic nephropathy via induction of the angiotensin II type 2 (AT2) receptor. Diabetologia 53 (2010), 2442–2451.
52. Shankaran, H., Ippolito, D.L., Chrisler, W.B., et al. Rapid and sustained nuclear-cytoplasmic ERK oscillations induced by epidermal growth factor. Mol Syst Biol, 5, 2009, 332.
53. Shin, S.Y., Rath, O., Choo, S.M., et al. Positive- and negative-feedback regulations coordinate the dynamic behavior of the Ras-Raf-MEK-ERK signal transduction pathway. J Cell Sci 122 (2009), 425–435.
54. Kim, S.H., Chang, J.W., Kim, S.B., et al. Myoglobin induces vascular cell adhesion molecule-1 expression through c-Src kinase-activator protein-1/nuclear factor-kappaB pathways. Nephron Exp Nephrol 114 (2010), e48–e60.
55. Gough, D.J., Sabapathy, K., Ko, E.Y., et al. A novel c-Jun-dependent signal transduction pathway necessary for the transcriptional activation of interferon gamma response genes. J Biol Chem 282 (2007), 938–946.